Senicapoc in Alzheimer's Disease

NCT04804241 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

55

Enrollment

OTHER

Sponsor class

Conditions

Mild Cognitive Impairment
Alzheimer Disease

Interventions

DRUG: Senicapoc
OTHER: Placebo Tablet

Sponsor

University of California, Davis

Collaborators

[object Object]
[object Object]
[object Object]